Web Results

www.sarfez.com/aboutus.html

Sarfez Pharmaceuticals, Inc. is a Virginia company focused on improving existing drugs using proprietary extended release formulation technology, repurposing ...

www.sarfez.com/contactus.html

Corporate Headquarters. Sarfez Pharmaceuticals, Inc. 1600 Tysons Boulevard Suite 800, 8th Floor McLean, VA 22102 --- Telephone 703-627-1934 ...

www.sarfez.com

Our Mission is to discover and develop better therapeutic options for patients suffering from unmanageable diseases. We understand that diseases are complex, ...

www.sarfez.com/pipeline.html

Current Research & Development Activities. Therapeutic Area: Cardiovascular and Renal Diseases. An Extended Release Loop Diuretic, currently the lead ...

www.sarfez.com/managementteam.html

Fatima Khwaja Chief Executive Officer. Dr. Khwaja has more than 20 years of experience in drug development and has been involved in drug repurposing ...

www.sbir.gov/sbirsearch/detail/1195525

R43HL134462. Solicitation Topic Code: NHLBI. Small Business Information. SARFEZ USA, INC. 8000 TOWER CRESCENT DR STE 1331, Vienna, VA, 22182 - ...

naartery.org/Resources/Documents/Final%20Program.pdf

Sep 7, 2013 ... Healthcare, Inc. The NAA is grateful to each of them for their support of ..... Consultant: Merck & Co, Sarfez Pharmaceuticals, IEM GmbH, MPM Capital, .... Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.

clinicaltrials.gov/ct2/show/NCT03215875

Jul 9, 2017 ... Verified July 2017 by Sarfez Pharmaceuticals, Inc. Sponsor: Sarfez Pharmaceuticals, Inc. Information provided by (Responsible Party):. Sarfez ...

grantome.com/grant/NIH/R43-HL134462-01

Sarfez USA, Inc., Vienna, VA, United States ... cardiovascular disease (ASCVD) is the leading cause of death and disability for men and women in the USA.